In the context of Alzheimer’s disease, legumain phosphorylation at S226 by SRPK2 led to accumulation of cytoplasmic legumain, promoting cleavage of tau, APP, and SRPK2 itself (110). This evidence concerns the gene MAPT and Alzheimer disease.